These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 23026276)

  • 1. Management of T2 esophageal cancer.
    Sancheti M; Fernandez F
    Surg Clin North Am; 2012 Oct; 92(5):1169-78. PubMed ID: 23026276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The accuracy of endoscopic ultrasonography with fine-needle aspiration, integrated positron emission tomography with computed tomography, and computed tomography in restaging patients with esophageal cancer after neoadjuvant chemoradiotherapy.
    Cerfolio RJ; Bryant AS; Ohja B; Bartolucci AA; Eloubeidi MA
    J Thorac Cardiovasc Surg; 2005 Jun; 129(6):1232-41. PubMed ID: 15942562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Staging in oesophageal cancer.
    Plukker JT; van Westreenen HL
    Best Pract Res Clin Gastroenterol; 2006; 20(5):877-91. PubMed ID: 16997167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significant understaging is seen in clinically staged T2N0 esophageal cancer patients undergoing esophagectomy.
    Dolan JP; Kaur T; Diggs BS; Luna RA; Sheppard BC; Schipper PH; Tieu BH; Bakis G; Vaccaro GM; Holland JM; Gatter KM; Conroy MA; Thomas CA; Hunter JG
    Dis Esophagus; 2016 May; 29(4):320-5. PubMed ID: 25707341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical impact of endoscopic ultrasound and endoscopic ultrasound-guided fine-needle aspiration in the management of rectal carcinoma.
    Shami VM; Parmar KS; Waxman I
    Dis Colon Rectum; 2004 Jan; 47(1):59-65. PubMed ID: 14719152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative effectiveness of upfront esophagectomy versus induction chemoradiation in clinical stage T2N0 esophageal cancer: A decision analysis.
    Semenkovich TR; Panni RZ; Hudson JL; Thomas T; Elmore LC; Chang SH; Meyers BF; Kozower BD; Puri V
    J Thorac Cardiovasc Surg; 2018 May; 155(5):2221-2230.e1. PubMed ID: 29428700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis and staging of cancer of the esophagus and esophagogastric junction.
    Li Z; Rice TW
    Surg Clin North Am; 2012 Oct; 92(5):1105-26. PubMed ID: 23026272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response monitoring of neoadjuvant therapy using CT, EUS, and FDG-PET.
    Sloof GW
    Best Pract Res Clin Gastroenterol; 2006; 20(5):941-57. PubMed ID: 16997171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is positron emission tomography useful in locoregional staging of esophageal cancer? Results of a multidisciplinary initiative comparing CT, positron emission tomography, and EUS.
    Sandha GS; Severin D; Postema E; McEwan A; Stewart K
    Gastrointest Endosc; 2008 Mar; 67(3):402-9. PubMed ID: 18178202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Staging and treatment of advanced esophageal cancer.
    von Rahden BH; Stein HJ
    Curr Opin Gastroenterol; 2005 Jul; 21(4):472-7. PubMed ID: 15930991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does FDG-PET add information to EUS and CT in the initial management of esophageal cancer? A prospective single center study.
    McDonough PB; Jones DR; Shen KR; Northup PG; Galysh RL; Hernandez A; White GE; Kahaleh M; Shami VM
    Am J Gastroenterol; 2008 Mar; 103(3):570-4. PubMed ID: 17941963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term results of a phase II trial of neoadjuvant chemotherapy followed by esophagectomy for locally advanced esophageal neoplasm.
    Pennathur A; Luketich JD; Landreneau RJ; Ward J; Christie NA; Gibson MK; Schuchert M; Cooper K; Land SR; Belani CP
    Ann Thorac Surg; 2008 Jun; 85(6):1930-6; discussion 1936-7. PubMed ID: 18498797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogenesis, diagnosis and therapeutic possibilities of esophageal cancer.
    Siersema PD
    Curr Opin Gastroenterol; 2007 Jul; 23(4):456-61. PubMed ID: 17545786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The utility of positron emission tomography for the diagnosis and staging of recurrent esophageal cancer.
    Flamen P; Lerut A; Van Cutsem E; Cambier JP; Maes A; De Wever W; Peeters M; De Leyn P; Van Raemdonck D; Mortelmans L
    J Thorac Cardiovasc Surg; 2000 Dec; 120(6):1085-92. PubMed ID: 11088030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of interval distant metastases: clinical utility of integrated CT-PET imaging in patients with esophageal carcinoma after neoadjuvant therapy.
    Bruzzi JF; Swisher SG; Truong MT; Munden RF; Hofstetter WL; Macapinlac HA; Correa AM; Mawlawi O; Ajani JA; Komaki RR; Fukami N; Erasmus JJ
    Cancer; 2007 Jan; 109(1):125-34. PubMed ID: 17146785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis and therapy in advanced cancer of the esophagus and the gastroesophageal junction.
    Lerut T; Coosemans W; Decker G; De Leyn P; Moons J; Nafteux P; Van Raemdonck D
    Curr Opin Gastroenterol; 2006 Jul; 22(4):437-41. PubMed ID: 16760764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Refining esophageal cancer staging after neoadjuvant therapy: importance of treatment response.
    Barbour AP; Jones M; Gonen M; Gotley DC; Thomas J; Thomson DB; Burmeister B; Smithers BM
    Ann Surg Oncol; 2008 Oct; 15(10):2894-902. PubMed ID: 18663531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of integrated computed tomography positron-emission tomography in esophageal cancer: staging and assessment of therapeutic response.
    Erasmus JJ; Munden RF
    Semin Radiat Oncol; 2007 Jan; 17(1):29-37. PubMed ID: 17185195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of neoadjuvant therapy for esophageal adenocarcinoma.
    Ku GY; Ilson DH
    Surg Oncol Clin N Am; 2009 Jul; 18(3):533-46. PubMed ID: 19500742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endoscopic and Imaging Predictors of Complete Pathologic Response After Chemoradiation for Esophageal Cancer.
    Uberoi GS; Uberoi AS; Bhutani MS
    Curr Gastroenterol Rep; 2017 Oct; 19(11):57. PubMed ID: 28983771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.